LCMS webinars focusing on LC/HRMS - page 1

The proteomic LC-MS strategy revealing autoimmune mechanisms with new clarity for clinical research

The proteomic LC-MS strategy revealing autoimmune mechanisms with new clarity for clinical research

Integrated proteomics and multiomics strategies are transforming the way researchers investigate immune dysregulation and disease mechanisms.
Tu, 19.5.2026 17:00 CEST
SelectScience
tag
share
more
The proteomic LC-MS strategy revealing autoimmune mechanisms with new clarity for clinical research
Advancing PFAS biomonitoring: What we measure and why it matters

Advancing PFAS biomonitoring: What we measure and why it matters

Explore how advanced LC-MS/MS, HRMS, and multi-omics reshape PFAS biomonitoring and health-risk assessment. Expert panel connects analytical science with clinical and regulatory decision-making.
Fr, 29.5.2026 17:00 CEST
SelectScience
tag
share
more
Advancing PFAS biomonitoring: What we measure and why it matters
Pharma fundamentals: To Be or Not to Be? QQQ vs HRMS Quant

Pharma fundamentals: To Be or Not to Be? QQQ vs HRMS Quant

Join this Pharma Fundamentals masterclass to compare sensitivity, selectivity, and workflow efficiency using SCIEX 7500+ and ZenoTOF 7600 systems.
Th, 11.6.2026 11:00 CET
SCIEX
tag
share
more
Pharma fundamentals: To Be or Not to Be? QQQ vs HRMS Quant
Accelerating LC/MS Impurity Screening Followed by ECD-Based Sequence Analysis for GLP-1 Analogs

Accelerating LC/MS Impurity Screening Followed by ECD-Based Sequence Analysis for GLP-1 Analogs

Episode 4 of Peptide 360 presents a staged LC/MS workflow for rapid GLP-1 impurity screening followed by ECD-based sequence analysis for precise structural confirmation and faster decisions.
RECORD
|
Already taken place Fr, 8.5.2026
Agilent Technologies
tag
share
more
Accelerating LC/MS Impurity Screening Followed by ECD-Based Sequence Analysis for GLP-1 Analogs
Integrated LC-MS CDS workflow for automated ADC and DAR analysis

Integrated LC-MS CDS workflow for automated ADC and DAR analysis

In this webinar, we’ll present an automated, high-throughput intact ADC workflow using LC-MS under native conditions on the Thermo Scientific Orbitrap Exploris 240 mass spectrometer.
RECORD
|
Already taken place We, 6.5.2026
Thermo Fisher Scientific
tag
share
more
Integrated LC-MS CDS workflow for automated ADC and DAR analysis
From Sample to Structure: Crosslinking MS Made Practical - Part 2

From Sample to Structure: Crosslinking MS Made Practical - Part 2

Crosslinking mass spectrometry (XL-MS) is transforming how researchers map protein–protein and protein–nucleic acid interactions.
RECORD
|
Already taken place Th, 30.4.2026
Thermo Fisher Scientific
tag
share
more
From Sample to Structure: Crosslinking MS Made Practical - Part 2
From Sample to Structure: Crosslinking MS Made Practical - Part 1

From Sample to Structure: Crosslinking MS Made Practical - Part 1

Crosslinking mass spectrometry (XL-MS) is transforming how researchers map protein–protein and protein–nucleic acid interactions.
RECORD
|
Already taken place Tu, 28.4.2026
Thermo Fisher Scientific
tag
share
more
From Sample to Structure: Crosslinking MS Made Practical - Part 1
Advancing and Characterizing Next-Gen Antibody Conjugates: Insights from BBB-Targeting Antibody Platforms

Advancing and Characterizing Next-Gen Antibody Conjugates: Insights from BBB-Targeting Antibody Platforms

Discover next-generation antibody therapeutics, BBB-targeting platforms, and LC-QTOF workflows for advanced characterization of complex antibody-drug and oligonucleotide conjugates.
RECORD
|
Already taken place Fr, 24.4.2026
Agilent Technologies
tag
share
more
Advancing and Characterizing Next-Gen Antibody Conjugates: Insights from BBB-Targeting Antibody Platforms
High-throughput activity based protein profiling - Systematic mapping of covalent drug-protein interactions on a proteome-wide scale

High-throughput activity based protein profiling - Systematic mapping of covalent drug-protein interactions on a proteome-wide scale

Part 3 of the Chemoproteomics Master Class highlights activity-based proteome profiling and covalent screening to accelerate target identification and drug discovery using scalable MS workflows.
RECORD
|
Already taken place Th, 23.4.2026
Thermo Fisher Scientific
tag
share
more
High-throughput activity based protein profiling - Systematic mapping of covalent drug-protein interactions on a proteome-wide scale
From experts to applications: Screening protein-drug interactions with HT-PELSA

From experts to applications: Screening protein-drug interactions with HT-PELSA

Part 2 of the Chemoproteomics Master Class explores HT-PELSA with Orbitrap Astral MS, showing peptide-level ligand binding analysis for target discovery, specificity, and drug pipeline insights.
RECORD
|
Already taken place We, 22.4.2026
Thermo Fisher Scientific
tag
share
more
From experts to applications: Screening protein-drug interactions with HT-PELSA
 

Related content

News from LabRulezLCMS Library - Week 20, 2026

News from LabRulezLCMS Library - Week 20, 2026

We, 13.5.2026
LabRulez
A comprehensive guide for selecting the appropriate HPLC detector

A comprehensive guide for selecting the appropriate HPLC detector

We, 13.5.2026
KNAUER
Tracking unspliced RNA: Professor Rumlová studies how retroviruses “hack” cells

Tracking unspliced RNA: Professor Rumlová studies how retroviruses “hack” cells

We, 13.5.2026
UCT Prague
Other projects
GCMS
ICPMS
Follow us
FacebookX (Twitter)LinkedInYouTube
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike